Publication | Open Access
Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study
94
Citations
26
References
2023
Year
Novo Nordisk A/S.
| Year | Citations | |
|---|---|---|
Page 1
Page 1